XRP spike on hoax filing a ‘bad look’ but won’t sway SEC’s ETF approvals By Cointelegraph

[ad_1]



The Nov. 13 (XRP) price action stemming from a falsified BlackRock (NYSE:) XRP trust filing shouldn’t sway the United States securities regulator’s decision to approve or delay spot (BTC) exchange-traded funds (ETFs) — but it isn’t a good look, say industry observers.

The Securities and Exchange Commission has previously claimed the Bitcoin market can be manipulated and has knocked back spot Bitcoin ETFs, citing a lack of market manipulation controls.

XRP filing ‘could easily undermine’ ETF efforts